|Titre :||HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities (2009)|
|Auteurs :||D. C. DES JARLAIS ; K. ARASTEH ; S. SEMAAN ; E. WOOD|
|Type de document :||Article : Périodique|
|Dans :||Current Opinion in HIV and AIDS (Vol.4, n°4, 2009)|
|Article en page(s) :||308-313|
|Discipline :||MAL (Maladies infectieuses / Infectious diseases)|
Thésaurus TOXIBASEVIH ; SALLE DE CONSOMMATION A MOINDRE RISQUE ; EPIDEMIOLOGIE ; USAGER ; INJECTION ; COHORTE ; METHODE ; STRUCTURE DE PROXIMITE ; CONDUITE A RISQUE ; HEPATITE
PURPOSE OF REVIEW: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs).
RECENT FINDINGS: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk.
SUMMARY: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners. [Author's abstract]
|Domaine :||Drogues illicites / Illicit drugs|
|Sous-type de document :||Revue de la littérature / Literature review|
|Refs biblio. :||52|
|Affiliation :||Beth Israel Medical Center, New York, NY, USA|